Given the association between obesity, IR, and PCOS, GLP-1R agonists were considered in the treatment of PCOS, and studies have shown that GLP-1R agonists do have therapeutic effects on PCOS. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.